Sep. 12 at 3:39 PM
$OSTX Analyst price targets for OSTX Several Wall Street analysts have issued price targets for OS Therapies (OSTX) in recent months, with notable upside from its current trading range. & • Stock AnalY-sis reports an average 12month price target of
$18.00, based on ratings from three analysts, with a low target of
$15.00 and a high of
$20.00. • Zacks shows an average short-term target of
$13.25 based on four analysts, with a low of
$6.00 and a high of
$20.00. • TiP-Ranks reports an average 12-month price target of
$12.50, based on forecasts from two analysts in the last three months, with a high of
$19.00 and a low of
$6.00. • Public.com provides an analyst price target of
$18.75, based on four analyst ratings. • The wide range of these price targets highlights the speculative nature of forecasting for a clinical-stage biotechnology company like OS Therapies. &
